Guidelines and realities of asthma management: The Philadelphia story

Archives of Internal Medicine

Volumn 157, Issue 11, 1997, Pages 1193-1200

  Lang, David M ^a   Sherman, Michael S ^a   Polansky, Marcia ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; STEROID; THEOPHYLLINE DERIVATIVE;

ARTICLE; ASTHMA; BRONCHODILATATION; HEALTH EDUCATION; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0030969007     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.11.1193     Document Type: Article

References (51)

1. Arrighi HM. US asthma mortality: 1941 to 1989. Ann Allergy. 1995;74:321-326.
2. Evans R III, Mullally DI, Wilson RW, et al. National trends in the morbidity and mortality of asthma in the US, prevalence, hospitalization, and death from asthma over two decades: 1965-1984. Chest. 1987;91(suppl):65S-74S.
3. Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia: 1969-1991. N Engl J Med. 1994;331:1542-1546.
4. Healthy People 2000: National Health Promotion ana Disease Objectives. Washington, DC: US Government Printing Office: 1990:317. US Dept of Health and Human Services publication (PHS) 91-50212.
5. Guidelines for the Diagnosis and Management of Asthma. Washington, DC: US Dept of Health and Human Services: 1991. Publication 91-3042.
6. Kemp J. Approaches to asthma management: realities and recommendations. Arch Intern Med. 1993;153:805-812.
7. Philpot EE, Kwasnicki JM. The impact of the NHLBI guidelines on asthma management in the prescribing habits of physicians at two community hospitals. J Allergy Clin Immunol. 1993;91:269A.
8. Ernst P. Spitzer WO, Suissa S, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA. 1992;268:3462-3464.
9. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. Chest. 1995;108:28-35.
10. Ferguson GT, Cherniak RM. Management of chronic obstructive pulmonary disease. N Engl J Med. 1993;328:1017-1022.
11. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995; 152(suppl 5):S77-S120.
12. Dorland's Medical Directory. 42nd ed. Philadelphia, Pa: Legal Communications Ltd;1994.
13. Vital Statistics Report: 1990. Philadelphia, Pa: Dept of Public Health; 1990.
14. Poverty in the United States: 1992. Washington, DC: US Government Printing Office; 1993. US Bureau of the Census, Current Population Reports, Series P-60-185.
15. Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariate Methods. Boston, Mass: PWS Kent Publishing Co; 1988.
16. Archie JP Jr. Mathematical coupling of data: a common source of error. Ann Surg. 1981;193:296-303.
17. Hoaglin DC, Mosteller F, Tukey JW, eds. Understanding Robust and Exploratory Data Analysis. New York, NY: John Wiley & Sons Inc; 1983.
18. Feldman JJ, Makuc DM, Kleinman JC, Cornoni-Huntley J. National trends in educational differentials in mortality. Am J Epidemiol. 1989;129:919-933.
19. Coultas DB, Gong H, Grad R, et al. Respiratory diseases in minorities in the United States. Am J Respir Crit Care Med. 1994;149(suppl 3):S93-S131.
20. Grain EF, Weiss KB, Bijur PE, Hersh M, Westbrook L, Stein REK. An estimate of the prevalence of asthma and wheezing among inner-city children. Pediatrics. 1994;94:356-362.
21. Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329:103-109.
22. Stamler J. Primary prevention of coronary heart disease: the last 20 years. Am J Cardiol. 1981;47:722-735.
23. Wilson RW, Elinson J. National survey of personal health practices and consequences: background, conceptual issues, and selected findings. Public Health Rep. 1991;96:218-225.
24. Mechanic D. Socioeconomic status and health: an examination of underlying processes. In: Bunker JP, Gomby DS, Kehrer BH, eds. Pathways to Health: The Role of Social Factors. Menlo Park, Calif: Henry J. Kaiser Foundation; 1989:9-26.
25. Finkelstein JA, Brown RW, Schneider LC, et al. Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics. 1995;95:389-394.
26. Wood PR, Hidalgo HA, Prihoda TJ, Krorher ME. Hispanic children with asthma: morbidity. Pediatrics. 1993;91:62-69.
27. Weiss KB, Gergen PJ, Grain EF. Inner city asthma: the epidemiology of an emerging US public health concern Chest. 1992;101(suppl 6):362S-367S.
28. British Thoracic Association. Death from asthma in two regions of England. BMJ. 1982;285:1251-1255.
29. Weissman JS, Stern R, Fielding SL, Epstein AM. Delayed access to health care: risk factors, reasons, and consequences. Ann Intern Med. 1991;114: 325-331.
30. Mak H, Johnston P, Abbey H. Talamo RC. Prevalence of asthma and health service utilization of asthmatic children in an inner city. J Allergy Clin Immunol. 1982;70:367-372.
31. Engel W, Freund DA, Stein JS, Fletcher RH. The treatment of patients with asthma by specialists and generalists. Med Care. 1989;27:306-314.
32. Harris JS. Why doctors do what they do: determinants of physician behavior. J Occup Med. 1990;32:1207-1220.
33. Clark TJH. Objectives of asthma management: the doctor's view, Eur Respir Rev. 1994;21:282-284.
34. 2-agonist and steroid dry powder inhaler in asthma. Am J Respir Crit Care Med. 1995;151:1053-1057.
35. Spector SL. Leukotriene inhibitors and antagonists in asthma. Ann Allergy. 1995; 75:463-473.
36. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med. 1994;154: 1349-1352.
37. Shulman NB, Martinez B, Brogan D, Carr AA, Miles CG. Financial cost as an obstacle to hypertension therapy. Am J Public Health. 1986;76:1105-1108.
38. Brand FN, Smith RT, Brand PA. Effect of economic barriers to medical care on patients' noncompliance. Public Health Rep. 1977;92:72-78.
39. Shea S, Misra D, Ehrlich MH, et al. Correlates of nonadherence to hypertension treatment in an inner-city population. Am J Public Health. 1992;82:1607-1612.
40. Parboosingh IJT, Lockyer JM, McDougall GM, Chugh I. How physicians make changes in their clinical practice: a study of physicians' perception of factors which facilitate this process. Ann R Coll Phys Surg Can. 1984;17:429-435.
41. Lockyer JM, Parboosingh JT, McDougall GM, Chugh U. How physicians integrate advances into clinical practices. Mobius. 1985;5:5-12.
42. Ziment I. Pharmacologic therapy of obstructive airway disease. Clin Chest Med. 1990;11:461-486.
43. Watson A, Lim TK, Joyce H, Pride NB. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction. Chest. 1992;101:350-355.
44. Wedzicha JA. Inhaled corticosteroids in COPD: awaiting controlled trials. Thorax. 1993;48:305-307.
45. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol. 1980;112:564-569.
46. Cockroft DW. Management of acute severe asthma. Ann Allergy. 1995;75:83-89.
47. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990;142:832-836.
48. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a β-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991;325:388-392.
49. Dompeling E, van Schayck CP, van Grunsven PM, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: a 4-year prospective study. Ann Intern Med. 1993;118:770-778.
50. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax. 1984;39:131-136.
51. Rutten-Van Molken MPMH, van Doorslaer EKA, Jansen MCC, van Essen-Zandvliet EE, Rutten FFH. Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma. Pharmacoeconomics. 1993;4:257-270.